🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07026370
Enrolling by invitation Observational

Chinese Population Health and Multimorbidity Study

NCT07026370 · tracked via the Priya Life Science China tracker
Sponsor
China-Japan Friendship Hospital
Phase
Observational
Started
2011-01-01
Last updated
2026-03-05

Condition(s) studied

Chronic Respiratory DiseasesCardiovascular and Cerebrovascular DiseasesMalignant TumorsEndocrine and Metabolic DiseasesMultimorbidities

Study summary

The Chinese Population Health and Multimorbidity Study (CPHMS; initially named China Pulmonary Health Study, CPHS) was a large-scale epidemiological survey designed to investigate the pulmonary health of Chinese adults aged 20 years or older leveraging a multistage stratified sampling scheme between 2011 and 2014 in mainland China. Briefly, a total number of 57,779 local residents were recruited from 10 representative provinces and municipalities and were invited to participate in the study. A final number of 50,991 adults who met the major inclusion criteria could be considered in further analyses.

In order to investigate the changes of pulmonary health and disease status (e.g. occurrence and development of chronic respiratory diseases and other important relevant multimorbidities, lung function indices, etc.) and corresponding impact factors in the CPHMS study population, we plan to initiate the first round of follow-up investigation between 2025 and 2027 (planned) , i.e. more than 10 years after the baseline survey.

Eligibility

Sex
ALL
Min age
20 Years
Max age
Healthy volunteers
Accepted
Inclusion Criteria: * (1) the individuals who participated in the CPHMS baseline survey; * (2) their ID number and phone number are available; * (3) sign the informed consent. Exclusion Criteria: * (1) incapable of taking pre- and post-bronchodilator spirometry tests; * (2) request to withdraw the informed consent; * (3) terminate due to medical or ethical considerations judged by the investigators and/or ethics committee.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
China-Japan Friendship Hospital Beijing Beijing Municipality

More China-Japan Friendship Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07026370 on ClinicalTrials.gov ↗ ← All trials in China